azithromycin and hydroxychloroquine accelerate mortality of outpatients with mild/moderate covid-19
azithromycin and hydroxychloroquine accelerate mortality of outpatients with mild/moderate covid-19
azithromycin (azm) and hydroxychloroquine (hcq) have proven their antiviral effect in vitro.